20 May 2013
Keywords: scripts, gsk, avandia, continue, fall, ims, health
Article | 02 July 2007
IMS Health's US prescription data for the week to June 15 shows the ongoing impact on prescribing levels of GlaxoSmithKline's anti-diabetes
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 July 2007
9 July 2007
25 June 2007
© 2013 thepharmaletter.com